skip to content
https://research-5iresearch.lpages.co/free-trial-5i-research-5i-blog/
Detailed Quote
5i Report
Rating
B+

Review of Savaria Corp.

AUG 25, 2017 - Accessibility and medical product provider that has recently closed an interesting acquisition while maintaining fundamentals. Rating upgraded to 'B+'.

Download Report
Company Profile
Interactive Chart
Key Ratios
Top Banner 5i Free Trial
Earnings
Analyst Recommendations
5i Recent Questions

Q: Hello Peter, Ryan, and Team

I need to raise some cash and would like to know how you would rank these stocks from "sell first" to "sell last":

BLX 1.07%
BNS 1.9%
KXS 1.35%
NFI 0.81%
PBH 1.7%
SIS 2.22%
SYZ 0.94%
TFII 0.58%

I am underwater on all of these. The number following each symbol is the stock's weighting.

Thanks for your assistance.

Read Answer Asked by Jerry on March 18, 2019

Q: Hi Gang, good news is I sold most of the above with gains except for COV and KXS, looking closer if I did not the losses would put me in big trouble, over 40% for most of them from the high, I know that 2018 was not a stellar year but I'm 65 years old and can't wait 5 years for these stocks to come back, do you have any thoughts on how to get out before a stock takes a 40% haircut, is a 8% or 10% stop rule help or perhaps farther out. Thanks Anthony

Read Answer Asked by Anthony on March 11, 2019
Insiders
CMS Buy Now
Share Information
News and Media